Hong Kong hospital chief quits

The chief executive of the Hong Kong Hospital Authority, William Ho, has become the fourth top health official to resign in the aftermath of Hong Kong's SARS crisis.

Written byKatherine Schlatter
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The chief executive of the Hong Kong Hospital Authority, William Ho, has become the fourth top health official to resign in the aftermath of Hong Kong's SARS crisis.

Ho called the crisis "the most difficult time in the entire history of the Hospital Authority." Ho himself fell ill with SARS during Hong Kong's outbreak in 2003. His illness prevented him from carrying out his duties, but also spared him from some of the heavy criticism heaped on other top officials during a legislative hearing about the crisis.

The former secretary for Health, Welfare, and Food, Yeoh Engkiong, and former Hospital Authority chairperson, Leong Chehung, took it upon themselves to step down a year ago at the hearing's conclusion. Another top health official, Margaret Chan, left Hong Kong to work at the World Health Organization just weeks after the SARS crisis ended.

Louis Shih Tai-cho, vice president of Hong Kong's Medical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies